Literature DB >> 27485235

Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?

Nikunj Satani1, Sean I Savitz2.   

Abstract

Inflammation within the brain and in peripheral tissues contributes to brain injury following ischemic stroke. Therapeutic modulation of the inflammatory response has been actively pursued as a novel stroke treatment approach for decades, without success. In recent years, extensive studies support the high potential for cell-based therapies to become a new treatment modality for stroke and other neurological disorders. In this review, we explore different types of cellular therapies and discuss how they modulate central and peripheral inflammatory processes after stroke. Apart from identifying potential targets for cell therapy, we also discuss paracrine and immunomodulatory mechanisms of cell therapy.

Entities:  

Keywords:  Cell-based therapy; Immune response; Inflammation; Microglia; Spleen; Stroke

Mesh:

Year:  2016        PMID: 27485235      PMCID: PMC5081125          DOI: 10.1007/s13311-016-0468-9

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  100 in total

1.  Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke.

Authors:  Bing Yang; Elton Migliati; Kaushik Parsha; Krystal Schaar; XiaoPei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Stroke       Date:  2013-10-10       Impact factor: 7.914

2.  CD25 signaling regulates the function and stability of peripheral Foxp3+ regulatory T cells derived from the spleen and lymph nodes of mice.

Authors:  Kunpeng Wang; Jian Gu; Xuhao Ni; Zheng Ding; Qi Wang; Haoming Zhou; SongGuo Zheng; Bin Li; Ling Lu
Journal:  Mol Immunol       Date:  2016-06-23       Impact factor: 4.407

3.  Cord blood rescues stroke-induced changes in splenocyte phenotype and function.

Authors:  Martina Vendrame; Carmelina Gemma; Keith R Pennypacker; Paula C Bickford; Cyndy Davis Sanberg; Paul R Sanberg; Alison E Willing
Journal:  Exp Neurol       Date:  2006-05-19       Impact factor: 5.330

4.  The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling.

Authors:  Hilary A Seifert; Christopher C Leonardo; Aaron A Hall; Derrick D Rowe; Lisa A Collier; Stanley A Benkovic; Alison E Willing; Keith R Pennypacker
Journal:  Metab Brain Dis       Date:  2012-02-22       Impact factor: 3.584

5.  Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler's Murine Encephalomyelitis.

Authors:  Vanessa Herder; Cut Dahlia Iskandar; Kristel Kegler; Florian Hansmann; Suliman Ahmed Elmarabet; Muhammad Akram Khan; Arno Kalkuhl; Ulrich Deschl; Wolfgang Baumgärtner; Reiner Ulrich; Andreas Beineke
Journal:  Brain Pathol       Date:  2015-01-23       Impact factor: 6.508

6.  Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume.

Authors:  Martina Vendrame; Jordan Cassady; Jennifer Newcomb; Tanya Butler; Keith R Pennypacker; Tanja Zigova; Cyndy Davis Sanberg; Paul R Sanberg; Alison E Willing
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

7.  Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma.

Authors:  Elisa R Zanier; Francesca Pischiutta; Loredana Riganti; Federica Marchesi; Elena Turola; Stefano Fumagalli; Carlo Perego; Emanuela Parotto; Paola Vinci; Pietro Veglianese; Giovanna D'Amico; Claudia Verderio; Maria-Grazia De Simoni
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

8.  Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population.

Authors:  Peter A Walker; Supinder S Bedi; Shinil K Shah; Fernando Jimenez; Hasen Xue; Jason A Hamilton; Philippa Smith; Chelsea P Thomas; Robert W Mays; Shibani Pati; Charles S Cox
Journal:  J Neuroinflammation       Date:  2012-09-28       Impact factor: 8.322

9.  Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model.

Authors:  Fei Zhou; Shane Gao; Lin Wang; Chenxi Sun; Lu Chen; Ping Yuan; Haiyang Zhao; Yi Yi; Ying Qin; Zhiqiang Dong; Limei Cao; Haiyan Ren; Liang Zhu; Qiang Li; Bing Lu; Aibin Liang; Guo-Tong Xu; Hongwen Zhu; Zhengliang Gao; Jie Ma; Jun Xu; Xu Chen
Journal:  Stem Cell Res Ther       Date:  2015-05-09       Impact factor: 6.832

10.  The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.

Authors:  Min Chen; Xifeng Li; Xin Zhang; Xuying He; Lingfeng Lai; Yanchao Liu; Guohui Zhu; Wei Li; Hui Li; Qinrui Fang; Zequn Wang; Chuanzhi Duan
Journal:  J Neuroinflammation       Date:  2015-04-01       Impact factor: 8.322

View more
  9 in total

Review 1.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

2.  Cell based therapy reduces secondary damage and increases extent of microglial activation following cortical injury.

Authors:  Mary E Orczykowski; Samantha M Calderazzo; Eli Shobin; Monica A Pessina; Adrian L Oblak; Seth P Finklestein; Brian C Kramer; Farzad Mortazavi; Douglas L Rosene; Tara L Moore
Journal:  Brain Res       Date:  2019-04-15       Impact factor: 3.252

Review 3.  Long Non-coding RNA HOTAIR in Central Nervous System Disorders: New Insights in Pathogenesis, Diagnosis, and Therapeutic Potential.

Authors:  Jialu Wang; Jiuhan Zhao; Pan Hu; Lianbo Gao; Shen Tian; Zhenwei He
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

4.  Autologous cellular therapy for cerebral palsy: a randomized, crossover trial.

Authors:  Charles S Cox; Jenifer Juranek; Steven Kosmach; Claudia Pedroza; Nivedita Thakur; Allison Dempsey; Kimberly Rennie; Michael C Scott; Margaret Jackson; Akshita Kumar; Benjamin Aertker; Henry Caplan; Fabio Triolo; Sean I Savitz
Journal:  Brain Commun       Date:  2022-05-20

Review 5.  Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke.

Authors:  Aldo Bonaventura; Luca Liberale; Alessandra Vecchié; Matteo Casula; Federico Carbone; Franco Dallegri; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

6.  World-Wide Efficacy of Bone Marrow Derived Mesenchymal Stromal Cells in Preclinical Ischemic Stroke Models: Systematic Review and Meta-Analysis.

Authors:  Nikunj Satani; Chunyan Cai; Kaavya Giridhar; Daryl McGhiey; Sarah George; Kaushik Parsha; Duyen M Nghiem; Krystal S Valenzuela; Jenny Riecke; Farhaan S Vahidy; Sean I Savitz
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

7.  Transplantation of Directly Reprogrammed Human Neural Precursor Cells Following Stroke Promotes Synaptogenesis and Functional Recovery.

Authors:  Ilan Vonderwalde; Ashkan Azimi; Gabrielle Rolvink; Jan-Eric Ahlfors; Molly S Shoichet; Cindi M Morshead
Journal:  Transl Stroke Res       Date:  2020-02       Impact factor: 6.829

Review 8.  Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke.

Authors:  Masato Kanazawa; Itaru Ninomiya; Masahiro Hatakeyama; Tetsuya Takahashi; Takayoshi Shimohata
Journal:  Int J Mol Sci       Date:  2017-10-13       Impact factor: 5.923

Review 9.  Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke.

Authors:  Courtney Davis; Sean I Savitz; Nikunj Satani
Journal:  Cells       Date:  2021-03-31       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.